SEATTLE--(BUSINESS WIRE)-- A six-year-old biotech company at the leading edge of regenerative medicine is bringing a therapy for Alzheimer’s to Phase I clinical trials that is expected to slow or stop … Read More
See the full list of PharmaVOICE 100 winners here.
Dr. Leen Kawas
Transforming Therapy for Neurodegenerative Diseases
Title: President and CEO
Company: M3 Biotechnology Inc.
Education: PhD, … Read More